During the early phase of the COVID‐19 pandemic in the United States, there was a significant reduction in cardiac catheterization lab activations and numbers of PPCIs for STEMI as well as an increase in door‐to‐balloon time.
The decrease in STEMI volume is likely multifaceted involving factors at the patient and health system levels.
Longitudinal data on STEMI care beyond the early phase of the pandemic is needed to better understand how different health systems have been adapting to the ongoing pandemic.